These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29426481)

  • 1. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice.
    Pensel P; Paredes A; Albani CM; Allemandi D; Sanchez Bruni S; Palma SD; Elissondo MC
    Vet Parasitol; 2018 Feb; 251():78-84. PubMed ID: 29426481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.
    Albani CM; Pensel PE; Elissondo N; Gambino G; Elissondo MC
    Vet Parasitol; 2015 Sep; 212(3-4):193-9. PubMed ID: 26190130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice.
    Enkai S; Kouguchi H; Inaoka DK; Irie T; Yagi K; Kita K
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1815-1820. PubMed ID: 33770336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albendazole solid dispersions against alveolar echinococcosis: a pharmacotechnical strategy to improve the efficacy of the drug.
    Fabbri J; Pensel PE; Albani CM; Lopez LM; Simonazzi A; Bermudez JM; Palma SD; Elissondo MC
    Parasitology; 2020 Aug; 147(9):1026-1031. PubMed ID: 32338226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albendazole-lipid nanocapsules: Optimization, characterization and chemoprophylactic efficacy in mice infected with Echinococcus granulosus.
    Ullio Gamboa GV; Pensel PE; Elissondo MC; Sanchez Bruni SF; Benoit JP; Palma SD; Allemandi DA
    Exp Parasitol; 2019 Mar; 198():79-86. PubMed ID: 30769018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
    Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
    PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis.
    Dvoroznáková E; Hrcková G; Borosková Z; Velebný S; Dubinský P
    Parasitol Int; 2004 Dec; 53(4):315-25. PubMed ID: 15464441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
    María AC; Celina EM
    Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
    Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
    Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental cystic echinococcosis therapy: In vitro and in vivo combined 5-fluorouracil/albendazole treatment.
    Pensel PE; Elissondo N; Gambino G; Gamboa GU; Benoit JP; Elissondo MC
    Vet Parasitol; 2017 Oct; 245():62-70. PubMed ID: 28969840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Oral Bioavailability and Anti-Echinococcosis Efficacy of Albendazole Achieved by Optimizing the "Spring" and "Parachute".
    Hu C; Liu Z; Liu C; Li J; Wang Z; Xu L; Chen C; Fan H; Qian F
    Mol Pharm; 2019 Dec; 16(12):4978-4986. PubMed ID: 31613633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice.
    Pensel PE; Ullio Gamboa G; Fabbri J; Ceballos L; Sanchez Bruni S; Alvarez LI; Allemandi D; Benoit JP; Palma SD; Elissondo MC
    Acta Trop; 2015 Dec; 152():185-194. PubMed ID: 26409727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of combined pentoxifylline and albendazole against echinococcus multilocularis infection in mice].
    Zhou HX; Mo JJ; Chen G; Bao GS; Shi DZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):333-6. PubMed ID: 17361810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
    Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
    Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.
    Ceballos L; Elissondo C; Sánchez Bruni S; Denegri G; Lanusse C; Alvarez L
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5861-7. PubMed ID: 21930885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis.
    Shuhua X; Jiqing Y; Mingjie W; Pieying J; Fanghua G; Junjie C; Wei J; Hotez P
    Acta Trop; 2002 Apr; 82(1):77-84. PubMed ID: 11904106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects.
    Bakhtiar NM; Akbarzadeh A; Casulli A; Mahami-Oskouei M; Ahmadpour E; Nami S; Rostami A; Spotin A
    Parasitol Res; 2019 Sep; 118(9):2455-2466. PubMed ID: 31402401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.
    Ceballos L; Elissondo C; Moreno L; Dopchiz M; Sánchez Bruni S; Denegri G; Alvarez L; Lanusse C
    Parasitol Res; 2008 Jul; 103(2):355-62. PubMed ID: 18465143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of albendazole-loaded nanostructured lipid carriers on Echinococcus granulosus microcysts and their prophylactic efficacy on experimental secondary hydatidosis.
    Farhadi M; Haniloo A; Rostamizadeh K; Ahmadi N
    Parasitol Res; 2021 Dec; 120(12):4049-4060. PubMed ID: 34669034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albendazole Nanocrystal-Based Dissolving Microneedles with Improved Pharmacokinetic Performance for Enhanced Treatment of Cystic Echinococcosis.
    Permana AD; Paredes AJ; Zanutto FV; Amir MN; Ismail I; Bahar MA; Sumarheni ; Palma SD; Donnelly RF
    ACS Appl Mater Interfaces; 2021 Aug; 13(32):38745-38760. PubMed ID: 34353029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.